bristol myers to buy adnexus new york bristol myers squibb co agreed to acquire adnexus therapeutics inc a closely held biotechnology company whose lead product is a cancer drug in early clinical trials for &# million adnexus based in waltham mass could receive earn out payments of as much as &# million in three increments of &# million each in the event certain milestones are achieved drug maker bristol myers agreed in february to pay about &# million over three years to help adnexus develop its class of drugs called adnectins they include an experimental cancer drug called angiocept which is in phase development 
